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Abstract
Toxicogenomics provides the ability to examine in greater detail the underlying molecular events
that precede and accompany toxicity, thus allowing prediction of adverse events at much earlier times
compared to classical toxicological endpoints. Acetaminophen (APAP) is a pharmaceutical that has
similar metabolic and toxic responses in rodents and humans. Recent gene expression profiling
studies with APAP found an oxidative stress signature at a sub-toxic dose that we hypothesized can
be phenotypically anchored to conventional biomarkers of oxidative stress. Liver tissue was obtained
from experimental animals used to generate microarray data where male rats were given APAP at
sub-toxic (150 mg/kg), or overtly toxic (1500 and 2000 mg/kg) doses and sacrificed at 6, 24, or 48
hrs. Oxidative stress in liver was evaluated by a diverse panel of markers that included assessing
expression of base excision repair (BER) genes, quantifying oxidative lesions in genomic DNA, and
evaluating protein and lipid oxidation. A sub-toxic dose of APAP produced significant accumulation
of nitrotyrosine protein adducts, while both sub-toxic and toxic doses caused a significant increase
in 8-hydroxy-deoxyguanosine. Only toxic doses of APAP significantly induced expression levels of
BER genes. None of the doses examined resulted in a significant increase in the number of abasic
sites, or in the amount of lipid peroxidation. The accumulation of nitrotyrosine and 8-hydroxy-
deoxyguanosine adducts phenotypically anchors the oxidative stress gene expression signature
observed with a sub-toxic dose of APAP, lending support to the validity of gene expression studies
as a sensitive and biologically-meaningful endpoint in toxicology.
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Toxicogenomics is an area in toxicology that elucidates how the entire genome is involved in
biological responses of organisms exposed to environmental toxicants. Expectations for this
new field have been high with promises of obtaining in much greater detail the molecular events
that precede and accompany toxicity, thus allowing prediction of a toxic insult at much earlier
stages than classical measures. Initial studies have been encouraging with gene-specific
signatures that predict and classify unknown hepatotoxicants based on a preliminary training
set of chemicals (Hamadeh et al. 2002). This work has led to the hypothesis that it is possible
to define signature patterns of altered gene expression that indicate specific adverse effects of
chemicals, drugs, or environmental exposures.
In order for gene expression profiling to become a well recognized and valuable tool in
toxicology, it should be characterized for its ability to reflect the results derived from classical
toxicology assays (e.g., histopathology, and clinical chemistry) in a dose- and time-dependent
manner (Paules 2003). Such phenotypic anchoring removes subjectivity from interpretation of
expression data by distinguishing between the toxicological effect signal from other gene
expression changes that may be unrelated to toxicity, such as the therapeutic effects of a
compound. Unfortunately, much of the available toxicogenomic data that has been published
to date, with few exceptions, has been limited to a description of alterations in gene expression
patterns.
Toxicology studies, in themselves, are quite complex with sources of variability resulting from
the dose and delivery of the chemical under study, the choice of animal species, and the
differences in biological and pathological responses of various tissues (Boorman et al. 2002).
The combination of this with the known technical variability in genomic studies (Bammler et
al. 2005) underscores the importance of careful validation of alterations in gene expression
patterns. In most cases, expression data can be phenotypically anchored using classical
toxicological methods; however, the apparent lack of sensitivity for most toxicity assays will
make this difficult for altered expression patterns observed at sub-toxic doses. Thus,
corroboration of such expression data sets will require the use of more sensitive, complex
assays.
The results of gene expression profiling studies can serve as a guide in the search for specific
genes and/or proteins that could be used as biomarkers of incipient toxicity, or can predict the
pathological changes that are yet to be realized by morphological analysis. Recently, a proof
of concept study was conducted whereby rats, the preferred model organism in toxicity testing,
were administered the hepatotoxicant, acetaminophen (APAP), and gene expression profiling
was performed (Heinloth et al. 2004). It was demonstrated that alterations in expression
patterns at a low, sub-toxic dose (i.e., no apparent toxicity was detected by histopathology or
clinical chemistry) may reveal signs of subtle cellular injury that are exacerbated at higher
doses. Specifically, it was found that altered gene expression patterns were suggestive of
mitochondrial dysfunction and oxidative stress and with increasing dose there was concomitant
increase in the magnitude of response and number of genes represented within the same vital
cellular pathways. However, the specificity of these gene expression changes to the mechanism
of APAP hepatotoxicity cannot be discerned without further research. Here, we have
undertaken a study to substantiate these findings of a gene expression signature for oxidative
stress by a sub-toxic of APAP in rat liver using a panel of sensitive biomarkers of oxidative
stress and oxidative DNA damage. The results of our studies show that a reduction in
glutathione (GSH) content in the liver alongside with the accumulation of nitrotyrosine protein
adducts and 8-hydroxy-deoxyguanosine lesions in DNA, events known to be a part of the mode
of action of APAP, provide good and early phenotypic anchors for gene expression signature
of APAP-induced oxidative stress, even at a sub-toxic dose.
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The studies detailed herein were performed using liver tissues (stored at −80°C) from
previously published report (Heinloth et al. 2004) where male Fisher 344 rats were
administered a single acute dose of acetaminophen by gavage at sub-toxic (150 mg/kg) or
overtly toxic (1500 and 2000 mg/kg) doses in 0.5% aqueous methyl cellulose. Animals were
sacrificed 6, 24, or 48 hrs following dosing at which point frozen and formalin-fixed liver
samples were collected.
Determination of Liver Tissue Glutathione Levels
Approximately 50 mg frozen liver tissue was homogenized in 5% sulfosalicyclic acid,
centrifuged at 8000 g for 10 min, and the supernatant assayed for reduced glutathione content
following manufacturer’s protocol (BioVision, Mountain View, CA).
Immunohistochemistry
Formalin-fixed, paraffin-embedded sections (6 μm) were mounted on glass slides. Sections
were deparaffinized in xylene, rehydrated in a series of graded alcohol concentrations, and
placed in phosphate-buffered saline (PBS) with 1% Tween 20. Immunostaining was performed
using DAKO EnVision System HRP (Dako Cytomation, Carpinteria, CA) with primary
antibody [1:200 nitrotyrosine (Molecular Probes; Eugene, OR); 1:200 malondialdehyde
(MDA; Alpha Diagnostic, San Antonio, TX); and 1:200 8-hydroxyguanosine (Research
Diagnostics; Flanders, NJ)] diluted in PBS containing 1% bovine serum albumin and incubated
overnight at 4°C. Slides were counterstained with hematoxylin. In order to ensure the
quantitative measurement of each immunoreaction, all sections from each animal and group
to be compared were processed in parallel. Antibody specificity was determined by incubating
each antibody with its respective antigen before immunostaining. Quantitative analysis of
immunostained liver sections was performed using BIOQUANT software (BIOQUANT Image
Analysis, Nashville, TN) by averaging percent area stained to total area within pericentral
regions at 200× with exception for 8-OH-dG where percentage of positively stained nuclei to
total nuclei in pericentral regions was determined.
Isolation of DNA
DNA was extracted by a procedure slightly modified from the method reported previously
(Nakamura et al. 2000). To minimize formation of oxidative artifacts during isolation, 2,2,6,6-
tetramethylpiperidinoxyl (TEMPO, 20 mM final concentration) was added to all solutions and
all procedures were performed on ice. Briefly, frozen tissues were thawed and homogenized
in PBS with a Tehran homogenizer (Wheaton Instruments, Millville, NJ). After centrifugation
at 2,000 x g for 10 min, the nuclear pellets were incubated in lysis buffer (Applied Biosystems,
Foster City, CA) overnight at 4°C with proteinase K (500 mg/ml; Applied Biosystems). DNA
was extracted twice with a mixture of phenol/chloroform/water followed by ethanol
precipitation. The extracted DNA was incubated in PBS (pH 7.4) with RNase A followed by
DNA precipitation with cold ethanol. Then, the DNA pellet was resuspended in sterilized
double distilled water. The DNA solution was stored at −80°C until assayed. The DNA
extraction method used in this study is unlikely to modify the original number of AP sites and
single strand breaks in genomic DNA from intact tissues or cells, based on re-extraction data
of DNA exposed to high concentrations of methylmethane sulfonate (Swenberg and Nakamura,
unpublished).
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AP sites were measured following a procedure reported by Nakamura and Swenberg
(Nakamura and Swenberg 1999). Briefly, 8 μg of DNA in 150 μl of phosphate-buffered saline
was incubated with 1 mM aldehyde reactive probe at 37°C for 10 min. After precipitation using
cold ethanol, DNA was resuspended in TE buffer (10 mM Tris-HCl, pH 7.4, containing 1 mM
EDTA). DNA (250 ng) in TE buffer was heat-denatured and loaded on a nitrocellulose
membrane (110 ng DNA/slot, Hybond-C Super, Amersham Pharmacia Biotech, Piscataway,
NJ). The nitrocellulose membrane was soaked with 5×SSC and then baked in a vacuum oven
for 30 min. The membrane was preincubated with 10 ml of Tris-HCl containing bovine serum
albumin for 15 min and then incubated in the same solution containing streptavidin-conjugated
horseradish peroxidase at room temperature for 45 min. After rinsing the nitrocellulose
membrane, the enzymatic activity on the membrane was visualized by enhanced
chemiluminescence reagents (Amersham). The nitrocellulose filter was exposed to x-ray film,
and the developed film analyzed using a Kodak Image Station 440. Quantitation was based on
comparisons to internal standard DNA containing a known amount of AP sites.
Detection and Quantification of 8-OH-dG by Capillary LC-MS/MS
The measurement of 8-OH-dG by LC-MS/MS was adapted from the method described by Liao
(Liao 2003). To digest DNA into individual nucleosides, DNA (30 to 50 μg) was dissolved in
80 mM Tris-HCl buffer/20 mM MgCl2 (pH 7.0) with 2.75 pmoles [15N5]-8-OH-dG internal
standard prior to digestion with 40U of DNase I for 10 min at 37°C. Next, 2.7 mU of
phosphodiesterase I and 2U of alkaline phosphatase were added and incubated for an additional
1h. The released 8-OH-dG was purified by reverse phase HPLC using a Beckman Ultrasphere
ODS C18 column (5 um, 4.6 x 250 mm, Beckman, Fullerton, CA). The isocratic mobile phase
was 7% MeOH in 10 mM ammonium formate (pH 4.3) with a flow rate 1 mL/min. Fractions
were collected 2 min preceding and following the elution of 8-OH-dG. The quantitative
analysis of 8-OH-dG by capillary LC-electrospray-MS/MS was performed with an 1100
capillary high-performance liquid chromatograph (Agilent, Wilmington, DE) coupled to a
TSQ-Quantum triple quad mass analyzer (ThermoFinnigan, San Jose, CA). A 3.5 μm Zorbax
XDB-C18 column (0.3 mm x 150 mm; Agilent) was operated with a binary mobile phase of
2% 10 mM ammonium formate (pH 4.3) and 98% methanol followed by a linear gradient
increase of methanol from 2% to 30% from 0 to 5 min, holding at 30% for 10 min, and
immediate return to initial conditions that was held for 15 min. Both analyte and internal
standard were detected by single reaction monitoring of the transition of nucleoside to base
adduct m/z 284.2 to 168.2 and m/z 289.2 to 173.2, respectively. MS conditions were as follows:
spray voltage, 2200 V; heated capillary temperature, 350°C. All reagents were purchased from
Sigma-Aldrich (St. Louis, MO) and were ACS grade or higher.
Ribonuclease protection assays
Total RNA was isolated using RNeasy total RNA (Qiagen, Valencia, CA) and dissolved in
RNase-free water. Samples were stored at −80°C until assayed. The quality of preparations
was determined using an Agilent Bio-Analyzer® (Agilent Technologies, Palo Alto, CA). The
RNase protection assays were performed on 20 μg of individual total RNA samples using a
RiboQuantTM multi-probe RNase protection assay kit (rBER, BD PharMingen, San Diego,
CA) essentially as described elsewhere (Rusyn et al. 2000). Riboprobes were synthesized in
the presence of [32P]dUTP to yield labeled antisense RNA probes. Protected fragments were
separated on 5% polyacrylamide nucleic acid separation gels, dried and exposed to x-ray film.
The intensity of protected bands was quantified using Kodak 1D Image Analysis Software
(New Haven, CT). Band intensity was normalized to the reference gene L32, which in our
experience has shown to be stably expressed in the liver without undue expression modulation
by various treatments.
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Results are reported as means ± SD with n = 3 in each group. Treatment groups were compared
using one-way ANOVA analysis followed by Tukey’s multiple comparison post-hoc test,
where appropriate. A p<0.05 was selected before the study to determine statistical differences
between groups.
RESULTS
A previous toxicogenomic study of APAP-induced toxicity in rat liver revealed an oxidative
stress signature with a sub-toxic dose at 6h that was also present after exposure to overtly toxic
doses (Heinloth et al. 2004). Specifically, this gene signature included the induction of cAMP
inducible gene 1, heterogenous nuclear ribonucleoproteins A1/B1, phospholipase C gamma1,
metallothionein (MT1a), phytoene dehydrogenase, and H2AX histone family. To substantiate
the link of this oxidative stress gene expression signature to incipient liver toxicity, we
examined the liver tissue from this earlier study to measure a diverse panel of endpoints for
oxidative stress and DNA damage. The study by Heinloth et al. (2004) also found that livers
of animals treated with a sub-toxic (150 mg/kg) dose of APAP were histologically
indistinguishable from controls. In contrast, rats treated with 1500 and 2000 mg/kg exhibited
mild to moderate centrilobular necrosis and inflammatory lesions that was most prominent at
24h and coincided with a significant increase in serum alanine aminotransferase (ALT) activity,
2952 ± 261 and 5047 ± 728, respectively.
Glutathione depletion by the reactive metabolite of APAP, N-acetyl-p-benzoquinone imine
(NAPQI), is thought to play an important causal role in APAP-induced hepatotoxicity. As such,
liver tissue from rats given a single acute dose by gavage of vehicle or APAP at sub-toxic (150
mg/kg) or overtly toxic (1500 mg/kg) doses at 6 and 24 hrs post-dosing were analyzed for
reduced GSH content. APAP treatment at sub-toxic and overtly toxic doses led to a 30 and
58% depletion of GSH content, respectively, compared to control animals at 6 hrs post-dosing
(Table 1). The GSH content in the liver of these animals returned to control levels by 24 hrs.
Peroxynitrite, an oxidant and nitrating species, is formed from the reaction of superoxide and
nitric oxide (NO·) which can lead to the formation of 3-nitrotyrosine protein adducts (Radi et
al. 1991; Pryor and Squadrito 1995). Liver sections from rats given a single acute dose by
gavage of vehicle or APAP at sub-toxic (150 mg/kg) or overtly toxic (1500 and 2000 mg/kg)
doses were examined for the presence of nitrotyrosine protein adducts by
immunohistochemistry. Control animals as well as those given an overtly toxic dose of APAP
exhibited minimal to non-detectable levels of nitrotyrosine (Figure 1A, 1C-D); in contrast, rats
given a sub-toxic dose of APAP exhibited extensive localized staining of hepatocytes within
pericentral regions of the liver lobule (Figures 1B and E) which resolved to control levels by
48hrs. Microscopic examination showed the presence of nitrotyrosine adducts within both
cellular and nuclear compartments of hepatocytes. Quantitative analysis of liver sections from
control animals showed that nitrotyrosine comprised less than 5% of total cellular area in
pericentral regions of the liver lobule as opposed to those given a sub-toxic dose of APAP
where nitrotyrosine comprised 80% and 30% of total cellular area at 6 and 24 hrs post-dosing,
respectively (Figure 1F).
The covalent binding of NAPQI to mitochondrial proteins can lead to an increased production
of reactive oxygen species (ROS) that can react with DNA (Mitchell et al. 1973b). First, we
examined 8-OH-dG, a widely-used marker of oxidative DNA damage, by
immunohistochemical detection (Figures 2A-C). Microscopic examination of liver sections
from control animals revealed sporadic distribution of positively stained nuclei but sections
from animals given either sub-toxic or overtly toxic dose had a concentration of positively
stained nuclei within the pericentral region (Figure 2D). Image analysis was performed to
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determine the percentage of positively stained nuclei (Figure 2E). Both sub-toxic and overtly
toxic doses of APAP led to a significant accumulation of 8-OH-dG adducts at 6 hrs post-dosing.
Then, we determined the amounts of 8-OH-dG after APAP treatment using a recently
developed capillary LC-MS/MS method as described in Materials and Methods. A calibration
curve was obtained by using 275.5 fmoles internal standard and variable amounts of 8-OH-dG
ranging from 0.5 to 228 fmoles/μl. The ratio of the peak areas of 8-OH-dG versus internal
standard was plotted against the known amounts of 8-OH-dG yielding a linear calibration curve
with a correlation coefficient of 1.0 (Figure 3A). Endogenous levels of 8-OH-dG in control rat
liver were ~ 1 adduct per 106 dG (Figure 3B), in agreement with recent consensus reports from
European Standards Committee on Oxidative DNA Damage (ESCODD 2003). Analysis of
liver tissues from rats treated with a sub-toxic and overtly toxic dose of APAP found a 3 to 4-
fold increase in 8-OH-dG adducts, respectively, over control (Figure 3B), confirming our
results with immunohistochemical detection.
It is believed that the predominant pathway used for removal of oxidized bases from DNA is
the base excision repair (BER) pathway. A multi-probe RNase protection assay for BER
enzymes was used, since this approach distinguishes the presence of multiple expressed DNA
repair genes simultaneously from a single sample, thus allowing for sensitive comparative
analysis of different mRNA products both within and between samples. Sub-toxic dose −150
mg/kg (data not shown), had no effect on expression of BER genes as compared to controls;
however, a time- and dose-dependent increase (1.5 to 3-fold) in mRNA for proliferating–cell
nuclear antigen (Pcna), poly ADP-ribose polymerase (Parp), AP endonuclease 1, 8-
oxoguanine DNA glycoslyase 1 (Ogg1), and polymerases β and δ was observed for 1500 mg/
kg dose of APAP (Table 2). In addition, expression of Mgmt, an enzyme involved in the direct
repair of alkylated guanine residues and not involved in repair of oxidative DNA lesions, was
unaffected in all treatments examined, conferring specificity to BER pathway.
Next, to determine whether the number of mutagenic and clastogenic apurinic/apyrimidinic
(AP) sites was increased following exposure to APAP, AP sites were measured using a slot
blot assay. AP sites can be generated spontaneously by chemical depurination of labile bases
and enzymatically by DNA glycosylases in a process of BER. In addition, ROS may induce
sugar lesions directly by hydrogen abstraction of deoxyribose, frequently resulting in oxidized
AP sites (Pogozelski and Tullius 1998). Although APAP at overtly toxic doses induced BER
genes as shown above, there were no significant increases in the number of AP sites generated
for any of the treatments (Figure 4).
Through the metabolic activation of APAP, both superoxide and peroxynitrite are generated
that subsequently may initiate lipid peroxidation by Fenton chemistry (Radi et al. 1991). Lipid
peroxidation was evaluated by immunostaining for malondialdehyde (Khan et al. 2002) in liver
sections from rats given vehicle, or a single acute dose by gavage of APAP at sub-toxic (150
mg/kg) and overtly toxic (1500 mg/kg) doses at 6, 24, or 48 hrs (Figures 5A–C). Quantitative
image analysis (Figure 5D) found no statistically significant difference (one-way ANOVA,
p<0.05) between treatment groups and controls.
DISCUSSION
In the present study, we investigated whether altered gene expression patterns that are
suggestive of oxidative stress at a sub-toxic dose of APAP, when no apparent toxicity was
detected using routine histopathological and clinical chemistry measurements, could be
phenotypically anchored by using a panel of sensitive biomarkers for oxidative stress and
oxidative DNA damage. Our results substantiate the previously reported gene expression
profiling data (Heinloth et al. 2004) demonstrating that the sub-toxic dose of APAP (150 mg/
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kg) does induce oxidative stress as demonstrated by the significant accumulation of
nitrotyrosine protein adducts, 8-OH-dG DNA lesions, and the reduction in GSH content 6 hrs
after treatment. This confirms that gene expression signatures can potentially serve as useful
sensitive indicators of toxicity. Furthermore, these data support the utility of gene expression
profiling as a sensitive and biologically-relevant endpoint in toxicology.
APAP is a common over-the-counter medication used for its analgesic and antipyretic
properties; however, it is also one of the leading causes of drug-induced liver failure
(Ostapowicz et al. 2002). At pharmacological doses, APAP is metabolized by sulfation and
glucuronidation, and to a lesser extent, by cytochrome CYP2E1 that produces a reactive
metabolite, NAPQI, which is detoxified by conjugation with GSH (Dahlin et al. 1984; Mitchell
et al. 1973a). APAP-induced hepatotoxicity occurs when GSH reserves are exhausted allowing
covalent binding of NAPQI to critical cellular proteins as APAP-cysteine adducts (Cohen et
al. 1997), ultimately disrupting their cellular function, see Scheme 1. Many of these covalently
bound proteins are within the mitochondria (Qiu et al. 1998) resulting in reduced respiration
(Donnelly et al. 1994) and increased superoxide production (Jaeschke 1990). Superoxide either
reacts with nitric oxide to produce peroxynitrite, which is responsible for protein nitration
(Hinson et al. 1998), or dismutates to hydrogen peroxide whereby it can oxidize cellular
macromolecules. The presence of nitric oxide, which is induced by APAP (Gardner et al.
1998), is thought to block propagation of lipid peroxidation (O'Donnell et al. 1997). It has been
postulated that loss of mitochondrial function and concomitant generation of oxidative stress
are central to APAP-induced hepatotoxicity (James et al. 2003a).
It is well recognized that the metabolic activation of APAP leading to GSH depletion is an
important step in APAP-induced liver toxicity. As expected, an overtly toxic dose of APAP
given to rats significantly reduced GSH content to 60% less than control at 6 hrs post-dosing.
Most surprisingly, a sub-toxic dose also significantly reduced GSH, albeit to a lesser extent.
This data suggests that depletion of GSH must reach a certain threshold for toxicity to ensue
and may explain why there is no apparent clinical signs of toxicity with a sub-toxic dose of
APAP.
A number of studies have reported elevated levels of nitrotyrosine protein adducts that precede
and accompany APAP-induced hepatotoxicity in mice (Hinson et al. 1998; James et al.
2003b). In this study, only rats given a sub-toxic dose of APAP, not overtly toxic doses, had
significantly elevated levels of nitrotyrosine protein adducts in liver compared to controls at 6
and 24 hrs post-dosing. The detection of these adducts was limited to the pericentral regions
of the liver where metabolic activation of APAP would occur and toxicity would develop at
higher doses. Also, an inverse relationship appears to exist between the levels of nitrotyrosine
protein adducts and GSH content in the liver. Between 6 and 24 hrs, the levels of nitrotyrosine
decreased from 17- to 8-fold over controls. The reduction in nitrotyrosine protein adducts
during this time may be due to several contributing factors such as enzymatic reversal of protein
nitration (Kamisaki et al. 1998), increased rate of protein degradation (Gow et al. 1996), as
well as decreased ROS production with concomitant recovery of GSH content in the liver.
The detection of nitrated protein adducts with a sub-toxic dose of APAP support the presence
of oxidant stress as indicated by earlier gene expression studies. However, the inability to detect
these adducts with overtly toxic doses demonstrates that the oxidant species formed in the
presence of sub-toxic and overtly toxic doses of APAP in the rat are not identical. It has been
shown that nitration of tyrosine residues is not limited to peroxynitrite exposure but can occur
via peroxidase enzymes such as glutathione peroxidase (Gaut et al. 2002) which is impaired
during APAP toxicity. In addition, it has been demonstrated that APAP is highly effective at
preventing tyrosine nitration by peroxynitrite (Whiteman et al. 1996; Lakshmi et al. 2000).
Thus, in this study overtly toxic doses of APAP, unlike sub-toxic doses, may be able to compete
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with tyrosine for peroxynitrite which may explain the differences observed with nitrotyrosine
levels between these two dosing groups. Moreover, this data would suggest that nitrotyrosine
is not associated with APAP-induced hepatotoxicity in the rat; an observation that is in direct
opposition to what has been observed in numerous studies with mice. This may well reflect a
mechanistic difference in APAP metabolism between these two rodent species.
The generation of ROS by either APAP metabolism or resulting mitochondrial damage can
lead to direct or indirect oxidative DNA damage. Immunohistochemical and mass spectrometry
methods found a significant accumulation of the potentially mutagenic DNA lesion, 8-OH-dG,
at sub-toxic and overtly toxic doses of APAP. Accumulation of 8-OH-dG lesions preceded the
onset of hepatic injury as reported by ALT and histopathology. The formation of 8-OH-dG
from APAP exposure potentially results from mitochondrial oxidant stress where both
superoxide and peroxynitrite are produced and can either directly or indirectly oxidize guanines
in DNA (Douki and Cadet 1996; Steenken 1989).
Recently, the quantified expression of base excision DNA repair (BER) genes was shown to
be a sensitive in vivo biomarker of chemical-induced oxidative stress (Rusyn et al. 2000).
Moreover, because this pathway encompasses broad specificity and multiple routes of repair,
it allows greater sensitivity in the ability to detect oxidative DNA damage. The measurement
of multiple genes involved in the BER pathway by an RNase protection assay was able to detect
up-regulation of gene expression that correlated with the onset of centrilobular hepatic necrosis
in addition to the rise and fall of ALT. However, the assay was unable to detect significant
increases of BER genes at a sub-toxic dose where genomic profiling generated an oxidative
stress signature that consisted primarily of genes that are involved in protecting the cell from
oxidative stress. It is known that the redox state of the cell is one of many mechanisms involved
in activating transcription factors involved in regulating the expression of DNA repair genes
(Fritz et al. 2003). Thus, it may be that at sub-toxic doses of APAP the apparent increase in
expression of anti-oxidants, such as metallothioneins, may be sufficient in maintaining redox
equilibrium.
The accumulation of apurinic/apyrimidinic (AP) sites can result from oxidative DNA damage
through an intermediary step of BER pathway, enzymatic cleavage, and chemical depurination.
The induction of BER pathway and, in particular, AP endonuclease gene by APAP was not,
however, corroborated by the accumulation of AP sites by any of the APAP treatments
examined. A lack of evidence for an increase in AP sites may be manifested in the limited dose
and time regimens examined in this study. Since the development of APAP toxicity typically
occurs within the first 6h of exposure, the detection of abasic sites would be limited if repair
occurred rapidly. Alternatively, the repair pathway could involve another route whereby
generation of an abasic site is obsolete. The dissociation between expression of BER genes
and accumulation of AP sites is not an unusual phenomenon and has been observed with other
chemical hepatotoxicants (Rusyn et al. 2000).
The role of lipid peroxidation in APAP-induced hepatotoxicity has been controversial (Wendel
et al. 1979; Knight et al. 2003; Hinson et al. 2002). Mitochondrial dysfunction leads to both
increased production of superoxide and formation of peroxynitrite that are both capable of
initiating lipid peroxidation; however, biochemical studies have shown that nitric oxide can
prevent the propagation of lipid peroxidation reactions (O'Donnell et al. 1997). This is
supported by the fact that inhibiting nitric oxide production during APAP exposure leads to
enhanced lipid peroxidation (Hinson et al. 2002). Our studies revealed that lipid peroxidation,
as measured by the presence of malondialdehyde, was not observed to be significant for any
doses or times examined. Despite the generation of ROS/RNS by APAP, our work does not
support the role of lipid peroxidation as a mediator of APAP-induced hepatotoxicity.
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It should be considered that alterations in gene expression that are potentially indicative of
cellular injury with an adverse outcome but are unsubstantiated by classical measures of
toxicity may be a mere reflection of the tissue’s capacity to cope. As demonstrated in this study,
an APAP-induced oxidant signature generated by a sub-toxic dose was corroborated using
sensitive biomarkers for oxidative stress and DNA damage. However, the presence of genes
having an anti-oxidant role within this signature may explain the lack of observable toxicity
by classical measures. In order to discern whether gene expression alterations in critical cellular
pathways represent benign homeostatic adjustments, indications of the potential for adverse
effects or in fact represent adverse effects, especially at doses and times with no observable
toxicity, will require the application of more sophisticated and sensitive tools that provide a
mechanistic link between a chemical and the observed toxic effect.
In general, the acceptance of microarray expression data as a relevant endpoint in toxicological
studies requires careful interpretation and validation. It has been suggested that this should be
achieved using classical toxicological endpoints such as histopathology and clinical chemistry
(Henry et al. 2002). One of the great promises of toxicogenomics is that it will be able to detect
and predict toxicity at much earlier stages compared to existing methods; however, restricting
validation of expression data to only classical endpoints, with their inherent lack of sensitivity,
would bring the advancement of toxicogenomics as well as toxicology to an impasse. Most
importantly, the enhanced sensitivity of microarray studies to detect subtle, early alterations
in vital cellular pathways that may be indicative of adverse effects, but display no observable
toxicity by conventional measures, can have serious ramifications in policy and regulatory
decision making.
In summary, we show that incipient signs of oxidative stress can be observed with a sub-toxic
dose of APAP based on the significant accumulation of both nitrotyrosine protein adducts and
8-OH-dG DNA lesions, markers anchored on the mechanism of APAP-induced liver toxicity.
The use of sensitive biomarkers of oxidative stress and oxidative DNA damage revealed not
only that mechanistic differences may exist in APAP metabolism between sub-toxic and
overtly toxic doses in rats but also among rodent species. Gene expression profiling is a
sensitive tool capable of detecting subtle cellular disturbances at doses and times unobtainable
by classical toxicological measures. Thus, it has the potential to serve an essential role in
predicative toxicology by generating gene signatures as biomarkers of incipient toxicity.
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Figure 1. A Sub-toxic dose of acetaminophen significantly increases nitro-tyrosine protein adducts
in rat liver
Representative micrographs (200×) of liver tissue from rats immunostained for nitrotyrosine
after treatment with (A) methyl cellulose control or (B) 150 mg/kg acetaminophen at 6, 24,
and 48hrs post-dosing and (C) 1500 mg/kg and (D) 2000 mg/kg acetaminophen at 6 hrs post-
dosing*. Representative micrograph (40×) of liver tissue from rats after treatment with 150
mg/kg acetaminophen demonstrating centralobular localization of nitrotyrosine staining (D).
CV, central vein; PV, portal vein. Immunostained liver sections for control (☐) and 150 mg/
kg (■) APAP were quantified by averaging percent area stained to total area at 200× in
pericentral regions (F). Data are presented as mean ± SD, n = 3 biological replicates per group.
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Data significantly different from control, p < 0.01, is denoted by asterisk. *Analysis of overtly
toxic doses of APAP at 24 and 48 hrs post-dosing was not performed due to the extensive
presence of necrotic tissue that often stains non-specifically.
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Figure 2. Rat liver genomic DNA significantly accumulates 8-OH-dG adducts after 6 hrs treatment
with sub-toxic and overtly toxic doses of acetaminophen
Representative micrographs (200×) of liver tissue immunostained for 8-OH-dG from rats
treated with (A) methyl cellulose control, (B) 150 mg/kg, or (C) 1500 mg/kg acetaminophen
6 hrs post-dosing. Representative micrograph (40×) of liver tissue from rats after treatment
with 150 mg/kg acetaminophen demonstrating centralobular localization of 8-OH-dG adducts
(D). . CV, central vein; PV, portal vein. Immuno-stained liver sections for control (☐), 150
mg/kg (■), or 1500 mg/kg (  ) APAP were quantified by averaging percent nuclei stained to
total nuclei within pericentral regions at 200× (E). Data are presented as mean ± SD, n = 3
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biological replicates per group. Data significantly different from control, p < 0.05, is denoted
by asterisk. ND = not determined
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Figure 3. A sub-toxic dose of APAP significantly accumulates 8-OH-dG DNA adducts in rat liver
as measured by capillary LC-MS/MS
(A) Standard calibration curve for 8-OH-dG by capillary LC-MS/MS. The ratio of the peak
areas of 8-OH-dG (AS) to 275.5 fmoles [15N5]-8-OH-dG (AI) as the internal standard plotted
against the amount of 8-OH-dG ranging from 5.5 to 228 fmoles/μl. (B) Quantitative measure
of 8-OH-dG DNA adducts in rat liver from control (☐), 150 mg/kg (■), or 1500 mg/kg ( )
APAP. Data are presented as mean ± SD from 3 animals per group. *Statistical difference (p
< 0.05) from control group using one-way ANOVA followed by Tukey’s multiple comparison
post-hoc test.
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Figure 4. Acetaminophen has no effect on the accumulation of apurinic/apyrimidinic (AP) sites in
rat liver
The number of AP sites in genomic DNA isolated from livers of control (☐) and 150 mg/kg
(■), or 1500 mg/kg ( ) APAP at 6, 24, and 48h. The control is pooled RNA from three
biological replicates and then 6, 24, and 48h time points averaged together. Data is given as
mean ± SD, n = 3. Statistical analysis by one-factor ANOVA (p < 0.05) found no significant
difference between acetaminophen treated groups and control.
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Figure 5. Acetaminophen does not promote lipid peroxidation in rat liver
Representative micrographs (200×) of liver tissue immunostained for malondialdehyde from
rats treated with (A) methyl cellulose control, (B) 150 mg/kg, or (C) 1500 mg/kg
acetaminophen 6 hrs post-dosing. Immunostained liver sections for control (☐), 150 mg/kg
(■), or 1500 mg/kg ( ) APAP were quantified by averaging percent area stained to total area
at 200× in pericentral regions (D). Data are presented as mean ± SD, n = 3 biological replicates
per group. Statistical analysis by one-factor ANOVA (p < 0.05) found no significant difference
between acetaminophen treated groups and control. ND = not determined.
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Phenotypic anchors of gene expression profiling for oxidative stress are a reflection of the
proposed mechanism of APAP-induced hepatotoxicity. APAP is metabolized by cytochrome
P450s to a reactive metabolite, N-acetyl-p-benzoquinone imine (NAPQI), which depletes
glutathione (GSH) and covalently binds to cellular proteins as APAP-cysteine adducts.
Mitochondrial injury leads to increased production and release of reactive oxygen and nitrogen
species that promotes oxidative stress and DNA damage. The depletion of GSH and coupling
reaction of superoxide (O2·−) and nitric oxide (NO·) leads to formation of peroxynitrite
(ONOO−) that reacts with protein tyrosine residues. It has been proposed that the production
of NO·, induced by APAP, terminates lipid peroxidation propagation. The concomitant loss of
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mitochondrial function and generation of oxidative stress are postulated to have a central role
in APAP-induced hepatoxicity. The sequence of events involved in APAP-induced
hepatatoxicity are shown in bold, whereas the markers of oxidative stress and oxidative DNA
damage measured in this study are shown in italics. *, markers that anchored gene expression
signature suggestive of oxidative stress with a sub-toxic dose of APAP. The scheme is a
summation of previously published reports on APAP-induced hepatotoxicity, see Discussion.
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Table 1
Reduced glutathione concentration in rat liver following acetaminophen treatment.
μmoles rGSH/g liver
Time Control 150 mg/kg 1500 mg/kg
6h 5.5 ± 0.43 3.8 ± 0.13* 2.3 ± 0.15*
24h 5.2 ± 0.68 5.9 ± 0.02 4.6 ± 0.75
Rats were administered a single acute dose of acetaminophen by gavage at sub-toxic (150 mg/kg) or overtly toxic (1500 mg/kg) doses in 0.5% aqueous
methyl cellulose (vehicle control). Liver tissue collected at 6 or 24h post-dosing was analyzed for reduced glutathione (rGSH) content as described in
Materials and Methods. Hepatic rGSH concentration is expressed as μmoles/g liver ± standard deviation from 3 animals per group.
*
Statistical difference (p < 0.01) from control group using one-way ANOVA followed by Tukey’s multiple comparison post-hoc test.
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Table 2
Expression of DNA repair genes in rat liver after treatment with an overtly toxic dose (1500 mg/kg) of
acetaminophen.
DNA Repair Gene Control 6h 24h 48h
Ogg1, 8-oxoguanine DNA glycosylase 1 3.8 ± 0.8 3.9 ± 0.8 8.2 ± 2.8* 10.2 ± 1.5*
Mpg, N-methylpurine DNA glycosylase 6.0 ± 0.4 5.2 ± 1.3 4.8 ± 2.7 4.0 ± 0.8
Ape, purinic/apyrimidinic endonuclease 1 23.5 ± 1.4 21.6 ± 5.2 34.8 ± 2.8* 30.8 ± 1.7
Pol β, polymerase (DNA directed) β 13.2 ± 0.9 11.9 ± 1.3 18.7 ± 1.8* 15.8 ± 1.2
Pol δ, polymerase (DNA directed) δ 1.5 ± 0.3 1.7 ± 1.7 6.0 ± 1.6* 8.8 ± 2.8*
Pcna, proliferating cell nuclear antigen 20.7 ± 2.1 22.5 ± 2.6 33.6 ± 7.9 50.9 ± 7.6*
Parp, poly (ADP-ribose) polymerase 15.3 ± 0.5 21.4 ± 1.3* 27.6 ± 3.8* 29.1 ± 1.6*
Mgmt, O6-methylguanine DNA
ethyltransferase
29.8 ± 1.3 24.1 ± 5.7 32.2 ± 6.6 32.1 ± 0.1
Total RNA was isolated from liver samples and analyzed by RNase protection assay. The results are mean ± standard deviation from 3 animals per group.
The relative expression of each gene was normalized to the expression of the housekeeping gene L32. The control is pooled RNA from three biological
replicates and then 6, 24, and 48h time points averaged together. The results from animals given a sub-toxic dose of APAP (150 mg/kg) are not presented
since they were not significantly different from controls.
*
Statistical difference (p < 0.05) from control group using one-way ANOVA followed by Tukey’s multiple comparison post-hoc test.
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